nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.05.2010 | FOCUS ON...

Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours

verfasst von: Giovanni Lucignani, Steven M. Larson

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Excerpt

“We believe that PET scan findings with FDG have prognostic value for high-grade gliomas and, in this respect, the PET-FDG technique is superior to CT or angiography. In addition, the PET-FDG grading of high-grade astrocytomas appears to be a more valuable prognostic criterion than the histological 20 typing [ 1 ].” Patronas NJ et al. 1985

…

Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg. 1985;62(6):816–22.CrossRefPubMed

Warburg O. The metabolism of tumors. London: Constable; 1930.

Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–33.CrossRef

Kinahan PE, Doot RK, Wanner-Roybal M, Bidaut LM, Armato SG, Meyer CR, et al. PET/CT assessment of response to therapy: tumor change measurement, truth data and error. Transl Oncol. 2009;2(4):223–30.PubMed

Nair VS, Krupitskaya Y, Gould MK. Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol. 2009;4(12):1473–9.CrossRefPubMed

Nair VS, Barnett PG, Ananth L, Gould MK, for the VA SNAP Cooperative Studies Group. Positron emission tomography (PET) 18F-fluorodeoxyglucose (FDG) uptake and prognosis in patients with resected, clinical stage Ia non-small cell lung cancer. Chest. 2009. doi:10.1378/chest.09-2356. Dec 28. [Epub ahead of print].

Dooms C, van Baardwijk A, Verbeken E, van Suylen RJ, Stroobants S, De Ruysscher D, et al. Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer. J Thorac Oncol. 2009;4(7):822–8.CrossRefPubMed

Okereke IC, Gangadharan SP, Kent MS, Nicotera SP, Shen C, DeCamp MM. Standard uptake value predicts survival in non-small cell lung cancer. Ann Thorac Surg. 2009;88(3):911–5. discussion 915–6.CrossRefPubMed

Hofele C, Freier K, Thiele OC, Haberkorn U, Buchmann I. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma. Oral Oncol. 2009;45(11):963–7.CrossRefPubMed

10.

Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys. 2009;74(4):1054–61.PubMed

11.

Pan L, Gu P, Huang G, Xue H, Wu S. Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2009;21(9):1008–15.CrossRefPubMed

12.

Kato H, Nakajima M, Sohda M, Tanaka N, Inose T, Miyazaki T, et al. The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer. 2009;115(14):3196–203.CrossRefPubMed

13.

Narayan K, Fisher RJ, Bernshaw D, Shakher R, Hicks RJ. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Int J Gynecol Cancer. 2009;19(5):912–8.PubMed

14.

Karam M, Ata A, Irish K, Feustel PJ, Mottaghy FM, Stroobants SG, et al. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome. Nucl Med Commun. 2009;30(10):770–8.CrossRefPubMed

15.

Furukawa H, Ikuma H, Asakura K, Uesaka K. Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma. J Surg Oncol. 2009;100(6):494–9.CrossRefPubMed

16.

Kruer MC, Kaplan AM, Etzl Jr MM, Carpentieri DF, Dickman PS, Chen K, et al. The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood. J Neurooncol. 2009;95(2):239–45.CrossRefPubMed

17.

Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, et al. The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Gynecol Oncol. 2009;115(1):65–8.CrossRefPubMed

18.

Cheon GJ, Kim MS, Lee JA, Lee SY, Cho WH, Song WS, et al. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI. J Nucl Med. 2009;50(9):1435–40.CrossRefPubMed

19.

Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, et al. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer. 2009;115(19):4586–94.CrossRefPubMed

20.

Xie P, Yue JB, Fu Z, Feng R, Yu JM. Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma. Ann Oncol. 2009. doi:10.1093/annonc/mdp430. Nov 13. [Epub ahead of print].PubMed

21.

Bartel TB, Haessler J, Brown TL, Shaughnessy Jr JD, van Rhee F, Anaissie E, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 2009;114(10):2068–76.CrossRefPubMed

22.

Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, et al. The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer. 2009;115(22):5184–92.CrossRefPubMed

Titel: Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours
verfasst von: Giovanni Lucignani
Steven M. Larson
Publikationsdatum: 01.05.2010
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2010
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-010-1428-y

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2010

Can an undetectable value of TG and a negative neck ultrasound study be considered reliable methods to assess the completeness of thyroid ablation?

Integrating imaging modalities: what makes sense from a workflow perspective?

Hybrid versus fusion imaging: are we moving forward judiciously?

Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience

High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications

Alpha particles more promising than toxins?